• Enterprise value to EBIT forward of Kyverna Therapeutics, Inc. – NASDAQ:KYTX TradingView Fri, 10 Jul 2026 02:45:24 GMT
• price to sales forward of kyverna therapeutics, inc. – nasdaq:kytx TradingView Thu, 09 Jul 2026 20:49:07 GMT
• Kyverna Therapeutics (KYTX) Jefferies London Healthcare Conference 2025 Summary Quartr Thu, 09 Jul 2026 17:16:43 GMT
• Kyverna Therapeutics’ (KYTX) Insights into Stiff Person Syndrome and Beyond Yahoo Finance Thu, 09 Jul 2026 13:22:54 GMT
• kyverna therapeutics, inc. files 8-k: key details on nasdaq listing, emerging growth status, and executive signatures Minichart Thu, 09 Jul 2026 11:27:00 GMT
• Kyverna Therapeutics (KYTX) extends access to $150M term loan tranches Stock Titan Thu, 09 Jul 2026 10:03:29 GMT
• Kyverna Therapeutics, Inc. $KYTX Shares Bought by AIGH Capital Management LLC MarketBeat Thu, 09 Jul 2026 08:21:23 GMT
• Kyverna Therapeutics: The Autoimmune CAR T Beachhead Is Bigger Than SPS (KYTX) Seeking Alpha Mon, 06 Jul 2026 11:15:59 GMT
• Kyverna Therapeutics, Inc.(NasdaqGS: KYTX) added to Russell 2000 Value Benchmark marketscreener.com Mon, 29 Jun 2026 16:01:36 GMT
• Kyverna Therapeutics, Inc.(NasdaqGS:KYTX) added to Russell Microcap Growth Benchmark Index marketscreener.com Mon, 29 Jun 2026 12:43:13 GMT
• Kyverna Therapeutics, Inc.(NasdaqGS: KYTX) added to Russell 3000 Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Kyverna Therapeutics, Inc.(NasdaqGS:KYTX) added to Russell Small Cap Comp Value Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• cabaletta bio: the market sold the eular news, i'm buying (nasdaq:caba) Seeking Alpha Fri, 26 Jun 2026 11:30:47 GMT
• kyverna therapeutics appoints ritesh srivastava chief legal, compliance officer TipRanks Mon, 22 Jun 2026 14:10:06 GMT
• kyverna's new legal chief: a strategic play for car-t dominance BriefGlance Mon, 22 Jun 2026 12:00:00 GMT
• Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Comme... Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• Kyverna adds legal chief as it prepares for commercialization Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• kyverna therapeutics inc (kytx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• kyverna therapeutics inc (kytx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 10:21:30 GMT
• kyverna therapeutics inc (kytx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 10:20:40 GMT
• kyverna therapeutics inc (kytx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 10:19:17 GMT
• Kyverna Therapeutics Inc (KYTX) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Thu, 18 Jun 2026 09:54:12 GMT
• kyverna therapeutics inc (kytx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 09:53:19 GMT
• kyverna therapeutics inc (kytx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 08:47:03 GMT
• kyverna therapeutics inc (kytx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 07:19:46 GMT
• kyverna therapeutics inc (kytx) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• kyverna therapeutics vs. vertex pharmaceuticals: which drug developer stock is a better buy in 2026? AOL.com Wed, 10 Jun 2026 08:13:50 GMT
• kyverna vs. vertex: clinical-stage risk vs. cash-flow stability in biotech investing - news and statistics IndexBox Mon, 08 Jun 2026 20:01:00 GMT
• Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026? The Motley Fool Mon, 08 Jun 2026 07:00:00 GMT
• Kyverna Therapeutics, Inc. (KYTX) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow Seeking Alpha Fri, 05 Jun 2026 07:00:00 GMT
• kytx stock price, quote & chart | kyverna therapeutics inc (nasdaq:kytx) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• advancing car t for drug-free remission in autoimmune disease with kyverna therapeutics' dr naji gehchan Bioprocess Online Thu, 04 Jun 2026 08:35:20 GMT
• h.c. wainwright reiterates kyverna stock rating on autoimmune data Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• morgan stanley maintains kyverna therapeutics(kytx.us) with buy rating, maintains target price $33 Moomoo Thu, 04 Jun 2026 07:00:00 GMT
• kytx reiterates by hc wainwright & co. -- price target maintained at $25 GuruFocus Thu, 04 Jun 2026 02:15:00 GMT
• kyverna therapeutics (kytx) jefferies global healthcare conference 2026 summary Quartr Wed, 03 Jun 2026 20:21:55 GMT
• kytx: miv-cel delivers durable, drug-free remission in sps and gmg with strong safety and market potential TradingView Wed, 03 Jun 2026 19:18:29 GMT
• kyverna therapeutics stock barely moves—the bigger car-t test is coming Bez Kabli Wed, 03 Jun 2026 17:25:21 GMT
• kyverna therapeutics, inc. files form 8-k announcing shareholder voting matters and company details (may 27, 2026) – minichart Minichart Wed, 03 Jun 2026 14:02:00 GMT
• kytx stock price, quote & chart | kyverna therapeutics inc (nasdaq:kytx) ChartMill Wed, 03 Jun 2026 10:16:57 GMT
• Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Posi... Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• New RA cell therapy clears disease-driving B cells in early trial Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Kyverna reports rheumatoid arthritis trial data at EULAR congress Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• william blair maintains kyverna therapeutics(kytx.us) with buy rating Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains kyverna therapeutics(kytx.us) with buy rating, maintains target price $25 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• investor deadline approaching: faruqi & faruqi, llp investigates claims on behalf of investors of kyverna therapeutics TMX Newsfile Tue, 02 Jun 2026 19:06:45 GMT
• Kyverna Therapeutics (KYTX) shareholders elect directors and ratify BDO as 2026 auditor Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• william blair maintains kyverna therapeutics(kytx.us) with buy rating 富途牛牛 Sat, 30 May 2026 06:05:28 GMT
• kyverna rises on new mid-stage trial data for myasthenia gravis therapy MSN Sat, 30 May 2026 05:48:45 GMT
• Kyverna Therapeutics (KYTX) director granted RSUs and options vesting in 2027 Stock Titan Fri, 29 May 2026 07:00:00 GMT
• Kyverna Therapeutics (KYTX) director receives new RSU and option awards Stock Titan Fri, 29 May 2026 07:00:00 GMT
• kyverna therapeutics (kytx) chair has shares withheld for rsu taxes Stock Titan Fri, 29 May 2026 07:00:00 GMT
• kyverna (nasdaq: kytx) director granted rsus and stock options in new form 4 Stock Titan Fri, 29 May 2026 07:00:00 GMT
• director aktar mert receives kyverna (kytx) rsu and stock option awards Stock Titan Fri, 29 May 2026 07:00:00 GMT
• kyverna rises on new mid-stage trial data for myasthenia gravis therapy MSN Fri, 29 May 2026 04:33:54 GMT
• h.c. wainwright maintains kyverna therapeutics(kytx.us) with buy rating, maintains target price $25 Moomoo Tue, 26 May 2026 07:00:00 GMT
• h.c. wainwright maintains kyverna therapeutics(kytx.us) with buy rating, raises target price to $25 富途牛牛 Thu, 21 May 2026 03:02:33 GMT
• Kyverna Therapeutics (KYTX) grants CFO Martini 325,000 stock options Stock Titan Wed, 20 May 2026 07:00:00 GMT
• cfo gregory martini (kytx) listed as insider in kyverna form 3 Stock Titan Wed, 20 May 2026 07:00:00 GMT
• KYTX: Transformative CAR-T therapy for SPS nears launch, with expansion into MG and MS underway TradingView Tue, 19 May 2026 07:00:00 GMT
• kyverna therapeutics names gregory martini as new cfo The Globe and Mail Tue, 19 May 2026 07:00:00 GMT
• kyverna therapeutics appoints greg martini as cfo to oversee financial operations geneonline.com Tue, 19 May 2026 07:00:00 GMT
• Kyverna Therapeutics Names Greg Martini as Chief Financial Officer Yahoo Finance Mon, 18 May 2026 07:00:00 GMT
• Kyverna taps ex-Ironwood CFO to fund CAR T autoimmune push Stock Titan Mon, 18 May 2026 07:00:00 GMT
• Kyverna Therapeutics Appoints Greg Martini CFO Ahead of Potential Commercial Launch citybiz Mon, 18 May 2026 07:00:00 GMT
• Press Release: Kyverna Therapeutics Names Greg Martini as Chief Financial Officer Moomoo Mon, 18 May 2026 07:00:00 GMT
• new kyverna (nasdaq: kytx) cfo greg martini receives cash and equity package Stock Titan Mon, 18 May 2026 07:00:00 GMT
• kyverna therapeutics appoints greg martini as chief financial officer Quiver Quantitative Mon, 18 May 2026 07:00:00 GMT
• kyverna appoints greg martini as chief financial officer Investing.com Mon, 18 May 2026 07:00:00 GMT
• kyverna rises on new mid-stage trial data for myasthenia gravis therapy MSN Mon, 18 May 2026 01:31:00 GMT
• kyverna rises on new mid-stage trial data for myasthenia gravis therapy MSN Sun, 17 May 2026 14:22:40 GMT
• press releases about kyverna therapeutics, inc. - common stock The Chronicle-Journal Fri, 15 May 2026 20:00:01 GMT
• kytx maintained by hc wainwright & co. -- price target raised to $25 GuruFocus Fri, 15 May 2026 12:22:30 GMT
• kyverna therapeutics price target raised to $25 from $20 at h.c. wainwright TipRanks Fri, 15 May 2026 10:53:48 GMT
• Kyverna CAR-T therapy for stiff person syndrome nears approval Labiotech.eu Fri, 15 May 2026 07:00:00 GMT
• h.c. wainwright maintains kyverna therapeutics(kytx.us) with buy rating, raises target price to $25 Moomoo Fri, 15 May 2026 07:00:00 GMT
• kytx stock price, quote & chart | kyverna therapeutics inc (nasdaq:kytx) ChartMill Fri, 15 May 2026 07:00:00 GMT
• tesla, irobot, servicenow, radiopharm theranostics, kyverna therapeutics: stocks making the biggest moves today MSN Thu, 14 May 2026 21:33:00 GMT
• morgan stanley maintains kyverna therapeutics(kytx.us) with buy rating, maintains target price $33 Moomoo Thu, 14 May 2026 11:14:51 GMT
• Kyverna Therapeutics to Present at Upcoming Investor Conferences Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• Watch Kyverna discuss autoimmune cell therapies at two live webcasts Stock Titan Thu, 14 May 2026 07:00:00 GMT
• kyverna therapeutics to present at two major investor conferences in may and june 2026 Pluang Thu, 14 May 2026 07:00:00 GMT
• assertio therapeutics buyout offer reflects 31% premium over original proposal geneonline.com Wed, 13 May 2026 15:05:12 GMT
• kyverna therapeutics price target lowered to $29 from $30 at jpmorgan TipRanks Wed, 13 May 2026 13:02:16 GMT
• Kyverna’s SPS CAR-T Therapy Advances to BLA Based on Natural History Study Data The Clinical Trial Vanguard Wed, 13 May 2026 07:00:00 GMT
• J.P. Morgan Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Announces Target Price $29 Moomoo Wed, 13 May 2026 07:00:00 GMT
• Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results The Manila Times Wed, 13 May 2026 07:00:00 GMT
• kyverna therapeutics, inc. stock 12‑month price target cut to $29.4, implies 187% upside TradingView Wed, 13 May 2026 07:00:00 GMT
• wells fargo maintains kyverna therapeutics(kytx.us) with buy rating, maintains target price $33 Moomoo Wed, 13 May 2026 07:00:00 GMT
• william blair maintains kyverna therapeutics(kytx.us) with buy rating Moomoo Wed, 13 May 2026 07:00:00 GMT
• kyverna therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 20:08:00 GMT
• "as the first company to submit a bla for an autoimmune car t therapy" Stock Titan Tue, 12 May 2026 20:02:00 GMT
• Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis Fierce Biotech Tue, 12 May 2026 07:00:00 GMT
• Kyverna starts first FDA BLA for autoimmune CAR T in SPS Stock Titan Tue, 12 May 2026 07:00:00 GMT
• Kyverna Therapeutics Begins BLA Submission and Releases First Quarter 2026 Financial Results geneonline.com Tue, 12 May 2026 07:00:00 GMT
• kyverna therapeutics | 8-k: kyverna therapeutics announces initiation of rolling sps bla submission and reports first quarter 2026... Moomoo Tue, 12 May 2026 07:00:00 GMT
• kyverna therapeutics announces initiation of rolling sps GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• kyverna therapeutics : investor presentation – may 2026 marketscreener.com Tue, 12 May 2026 07:00:00 GMT
• kyverna initiates rolling bla submission for autoimmune car t Investing.com Tue, 12 May 2026 07:00:00 GMT
• kyverna therapeutics (nasdaq: kytx) advances miv-cel sps bla and reports q1 2026 results Stock Titan Tue, 12 May 2026 07:00:00 GMT
• [10-q] kyverna therapeutics, inc. quarterly earnings report Stock Titan Tue, 12 May 2026 07:00:00 GMT
• number of shareholders of kyverna therapeutics, inc. – nasdaq:kytx TradingView Mon, 11 May 2026 14:29:40 GMT
• kyverna rises on new mid-stage trial data for myasthenia gravis therapy MSN Sat, 09 May 2026 06:17:02 GMT
• rfg advisory llc acquires shares of 445,200 kyverna therapeutics, inc. $kytx MarketBeat Thu, 07 May 2026 07:00:00 GMT
• kyverna therapeutics (kytx) chief commercial officer listed on form 3 Stock Titan Wed, 06 May 2026 07:00:00 GMT
• kyverna therapeutics (kytx) awards cco 300,000 stock options Stock Titan Wed, 06 May 2026 07:00:00 GMT
• kyverna therapeutics, inc. (nasdaq:kytx) receives consensus recommendation of "moderate buy" from analysts MarketBeat Wed, 06 May 2026 07:00:00 GMT
• kyverna therapeutics (kytx) stock surges 24% after hours: why is it moving? MSN Wed, 06 May 2026 05:17:11 GMT
• Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO Fierce Pharma Tue, 05 May 2026 07:00:00 GMT
• kyverna taps cco as car-t autoimmune first comes into view Fierce Pharma Tue, 05 May 2026 07:00:00 GMT
• kyverna therapeutics (kytx) to release earnings on tuesday MarketBeat Tue, 05 May 2026 07:00:00 GMT
• kyverna therapeutics appoints nadia dac as chief commercial officer TipRanks Mon, 04 May 2026 13:18:21 GMT
• press release: kyverna therapeutics appoints nadia dac, seasoned commercial leader in neurology and rare disease, as chief commerc... Moomoo Mon, 04 May 2026 12:00:00 GMT
Kyverna Therapeutics Inc(NASDAQ:KYTX) 
Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today reported its business highlights and financial results for the second quarter ended June 30, 2024.
Share this website to your friends